BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

497 related articles for article (PubMed ID: 21041381)

  • 21. [Expression and clinical significance of vascular endothelial growth factor and its receptors in multiple myeloma].
    Liu JR; Luo SK; Li J; Su C
    Ai Zheng; 2007 Jun; 26(6):652-6. PubMed ID: 17562275
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Vascular endothelial growth factor and two types of its receptors in breast cancer].
    Shcherbakov AM; Gershteĭn ES; Anurova OA; Kushlinskiĭ NE
    Vopr Onkol; 2005; 51(3):317-21. PubMed ID: 16279095
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The expression of VEGF receptor genes is concurrently influenced by epigenetic gene silencing of the genes and VEGF activation.
    Kim JY; Hwang JH; Zhou W; Shin J; Noh SM; Song IS; Kim JY; Lee SH; Kim J
    Epigenetics; 2009 Jul; 4(5):313-21. PubMed ID: 19633424
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Microvessel density and VEGF/VEGF receptor status and their role in sarcomas of the pulmonary artery.
    Gaumann AK; Schermutzki G; Mentzel T; Kirkpatrick CJ; Kriegsmann JB; Konerding MA
    Oncol Rep; 2008 Feb; 19(2):309-18. PubMed ID: 18202776
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential expression of vascular endothelial growth factor A, its receptors VEGFR-1, -2, and -3 and co-receptors neuropilin-1 and -2 does not predict bevacizumab response in human astrocytomas.
    Baumgarten P; Blank AE; Franz K; Hattingen E; Dunst M; Zeiner P; Hoffmann K; Bähr O; Mäder L; Goeppert B; Machein M; Seifert V; Steinbach JP; Plate KH; Harter PN; Mittelbronn M
    Neuro Oncol; 2016 Feb; 18(2):173-83. PubMed ID: 26627848
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Expression and significance of VEGF, miR-205 and target protein Ezrin and Lamin A/C in ovarian cancer].
    Zhou J; Liu H; Chen Y; Wen J; Li L; Wu X
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2014 Feb; 39(2):142-50. PubMed ID: 24608381
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Overexpression of vascular endothelial growth factor receptor 2 in pterygia may have a predictive value for a higher postoperative recurrence rate.
    Gumus K; Karakucuk S; Mirza GE; Akgun H; Arda H; Oner AO
    Br J Ophthalmol; 2014 Jun; 98(6):796-800. PubMed ID: 23376569
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Strong expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in ovarian borderline and malignant neoplasms.
    Abu-Jawdeh GM; Faix JD; Niloff J; Tognazzi K; Manseau E; Dvorak HF; Brown LF
    Lab Invest; 1996 Jun; 74(6):1105-15. PubMed ID: 8667614
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The expression of angiogenic growth factors and their receptors in ovarian follicles throughout the estrous cycle in the ewe.
    Chowdhury MW; Scaramuzzi RJ; Wheeler-Jones CP; Khalid M
    Theriogenology; 2010 Apr; 73(7):856-72. PubMed ID: 20042232
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of vascular endothelial growth factor-A in recurrent respiratory papillomatosis.
    Rahbar R; Vargas SO; Folkman J; McGill TJ; Healy GB; Tan X; Brown LF
    Ann Otol Rhinol Laryngol; 2005 Apr; 114(4):289-95. PubMed ID: 15895784
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intracranial meningiomas, the VEGF-A pathway, and peritumoral brain oedema.
    Nassehi D
    Dan Med J; 2013 Apr; 60(4):B4626. PubMed ID: 23651727
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic significance of immunohistochemical expression of the angiogenic molecules vascular endothelial growth factor-A, vascular endothelial growth factor receptor-1 and vascular endothelial growth factor receptor-2 in patients with classical Hodgkin lymphoma.
    Dimtsas GS; Georgiadi EC; Karakitsos P; Vassilakopoulos TP; Thymara I; Korkolopoulou P; Patsouris E; Kittas C; Doussis-Anagnostopoulou IA
    Leuk Lymphoma; 2014 Mar; 55(3):558-64. PubMed ID: 23772669
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased expression of vascular endothelial growth factor and its receptors, VEGFR-1 and VEGFR-2, in medullary thyroid carcinoma.
    Capp C; Wajner SM; Siqueira DR; Brasil BA; Meurer L; Maia AL
    Thyroid; 2010 Aug; 20(8):863-71. PubMed ID: 20615131
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Expression and clinical significance of VEGF and its receptors Flt-1 and KDR in nasopharyngeal carcinoma].
    Sha D; He YJ
    Ai Zheng; 2006 Feb; 25(2):229-34. PubMed ID: 16480593
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vascular endothelial growth factor A and vascular endothelial growth factor receptor 2 expression in non-small cell lung cancer patients: relation to prognosis.
    Bonnesen B; Pappot H; Holmstav J; Skov BG
    Lung Cancer; 2009 Dec; 66(3):314-8. PubMed ID: 19324448
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gene expression profile of vascular endothelial growth factor (VEGF) and its receptors in various cell types of the canine lymph node using laser capture microdissection (LCM).
    Jais A; Klein D; Wolfesberger B; Walter I
    Vet Immunol Immunopathol; 2011 Apr; 140(3-4):207-14. PubMed ID: 21211854
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Measurement of circulating levels of VEGF-A, -C, and -D and their receptors, VEGFR-1 and -2 in gastric adenocarcinoma.
    Al-Moundhri MS; Al-Shukaili A; Al-Nabhani M; Al-Bahrani B; Burney IA; Rizivi A; Ganguly SS
    World J Gastroenterol; 2008 Jun; 14(24):3879-83. PubMed ID: 18609713
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of vascular endothelial growth factor and its receptors in canine lymphoma.
    Wolfesberger B; Guija de Arespacohaga A; Willmann M; Gerner W; Miller I; Schwendenwein I; Kleiter M; Egerbacher M; Thalhammer JG; Muellauer L; Skalicky M; Walter I
    J Comp Pathol; 2007 Jul; 137(1):30-40. PubMed ID: 17467003
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Microvascularization and expression of VEGF and its receptors in recurring meningiomas: pathobiological data in favor of anti-angiogenic therapy approaches.
    Preusser M; Hassler M; Birner P; Rudas M; Acker T; Plate KH; Widhalm G; Knosp E; Breitschopf H; Berger J; Marosi C
    Clin Neuropathol; 2012; 31(5):352-60. PubMed ID: 22541785
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The relationship of the angiogenesis regulators VEGF-A, VEGF-R1 and VEGF-R2 to p53 status and prognostic factors in epithelial ovarian carcinoma in FIGO-stages I-II.
    Skirnisdottir I; Seidal T; Åkerud H
    Int J Oncol; 2016 Mar; 48(3):998-1006. PubMed ID: 26783205
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.